Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Nature Immunology
|
May 29, 2001
Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling
K Tedford, L Nitschke, I Girkontaite, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 29, 1999
The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens
M F Bachmann, L Nitschke, C Krawczyk, et al.
Leukemia
|
June 21, 2012
HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression
C Breitinger, E Maethner, M-P Garcia-Cuellar, et al.
Cell
|
June 13, 1997
A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
F Shalaby, J Ho, W L Stanford, et al.
European Journal of Immunology
|
June 8, 1999
The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation
J M Penninger, K D Fischer, T Sasaki, et al.
Nature
|
January 23, 1997
Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
H Nishina, K D Fischer, L Radvanyi, et al.
The Journal of Experimental Medicine
|
December 8, 1998
Vav regulates peptide-specific apoptosis in thymocytes
Y Y Kong, K D Fischer, M F Bachmann, et al.
Current Biology : CB
|
May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
K D Fischer, Y Y Kong, H Nishina, et al.
Development (Cambridge, England)
|
January 7, 1999
Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4
H Nishina, C Vaz, P Billia, et al.
The Journal of Experimental Medicine
|
September 18, 1997
Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes
H Nishina, M Bachmann, A J Oliveira-dos-Santos, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Nature Immunology
|
May 29, 2001
Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling
K Tedford, L Nitschke, I Girkontaite, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 29, 1999
The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens
M F Bachmann, L Nitschke, C Krawczyk, et al.
Leukemia
|
June 21, 2012
HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression
C Breitinger, E Maethner, M-P Garcia-Cuellar, et al.
Cell
|
June 13, 1997
A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
F Shalaby, J Ho, W L Stanford, et al.
European Journal of Immunology
|
June 8, 1999
The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation
J M Penninger, K D Fischer, T Sasaki, et al.
Nature
|
January 23, 1997
Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
H Nishina, K D Fischer, L Radvanyi, et al.
The Journal of Experimental Medicine
|
December 8, 1998
Vav regulates peptide-specific apoptosis in thymocytes
Y Y Kong, K D Fischer, M F Bachmann, et al.
Current Biology : CB
|
May 28, 1998
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
K D Fischer, Y Y Kong, H Nishina, et al.
Development (Cambridge, England)
|
January 7, 1999
Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4
H Nishina, C Vaz, P Billia, et al.
The Journal of Experimental Medicine
|
September 18, 1997
Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes
H Nishina, M Bachmann, A J Oliveira-dos-Santos, et al.
Page
of 5